OMICS A Journal of Integrative Biology · 2012 · 77 citations · 29 references
Life SciencesGeneticsMolecular BiologyGene ExpressionGene Expression AnalysisPathway AnalysisDifferential Gene Expression AnalysisExpression Signature DiscoveryGene Expression ProfilingPlacental BiologyPlacental PhysiologyDifferential Gene ExpressionExpression Fold Change AnalysisFold Change AnalysisMicroarray AnalysisPlacental GenomicsPlacental Signaling PathwaysTissue Expression ProfilesTissue Microarray Analysis
The purpose of this study was to perform a comprehensive analysis of gene expression profiles in placentas from preeclamptic pregnancies versus normal placentas. Placental tissues were obtained immediately after delivery from women with normal pregnancies (n=6) and patients with preeclampsia (n=6). The gene expression profile was assessed by oligonucleotide-based DNA microarrays and validated by quantitative real-time RT-PCR. Functional relationships and canonical pathways/networks of differentially-expressed genes were evaluated by GeneSpring™ GX 11.0 software, and ingenuity pathways analysis (IPA). A total of 939 genes were identified that differed significantly in expression: 483 genes were upregulated and 456 genes were downregulated in preeclamptic placentas compared with normal placentas (fold change ≥ 2 and p<0.05 by unpaired t-test corrected with Bonferroni multiple testing). The IPA revealed that the primary molecular functions of these genes are involved in cellular function and maintenance, cellular development, cell signaling, and lipid metabolism. Pathway analysis provided evidence that a number of biological pathways, including Notch, Wnt, NF-κB, and transforming growth factor-β (TGF-β) signaling pathways, were aberrantly regulated in preeclampsia. In conclusion, our microarray analysis represents a comprehensive list of placental gene expression profiles and various dysregulated signaling pathways that are altered in preeclampsia. These observations may provide the basis for developing novel predictive, diagnostic, and prognostic biomarkers of preeclampsia to improve reproductive outcomes and reduce the risk for subsequent cardiovascular disease.
29
Gene expression patterns in human placenta
Ruchira Sood, James L. Zehnder, Maurice L. Druzin et al. · Proceedings of the National Academy of Sciences · 2006 · 467 citations
Molecular Evidence of Placental Hypoxia in Preeclampsia
Nima Soleymanlou, Igor Jurišica, Ori Nevo et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 400 citations · Full text